Sandoparin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2009
01219902009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Sirs, Outpatient subcutaneous therapies are becoming more and more common, such as the use of low-molecular-weight heparins (LMWH… (More)
  • figure 1
Is this relevant?
2009
2009
Heparin is an injectable anticoagulant that prevents coagulation. There are presently high and low molecular heparins as well as… (More)
Is this relevant?
2004
2004
Niedermolekulare Heparine (NMH) werden aus unfraktioniertem Heparin dutch Gelchromatographie, Alkoholf/illung oder enzymatische… (More)
Is this relevant?
1995
1995
Recent studies have indicated a beneficial effect of one particular low molecular weight heparin preparation (Fragmin) on lipid… (More)
Is this relevant?
1995
1995
We report a patient who developed infiltrated plaques at the sites of subcutaneous injection of a low-molecular-weight heparin… (More)
Is this relevant?
1993
1993
In a prospective, randomized study in patients with hip fracture we discuss whether a single dose of low-molecular-heparin… (More)
Is this relevant?
1992
1992
A randomized open trial was undertaken to compare the antithrombotic efficacy of a low molecular weight heparin (LMWH; Sandoparin… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1992
1992
Since the beginning of the clinical use of low molecular weight (LMW) heparins their thrombolytic or profibrinolytic potency has… (More)
Is this relevant?
1990
1990
In three studies the effect and secondary effect of low molecular weight heparin (LMWH) were examined. Study 1: LMWH (Embolex-LM… (More)
Is this relevant?